Clinical Trials

    Neoadjuvant Atezolizumab in Patients With Non-Metastatic Resectable High-Risk Cutaneous Melanoma

    Investigator: Nestor Esnaola

    Study Coordinator: Safiya Joseph

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT04020809

    Phone: 203.308.8567

    Protocol Number: Pro00021957

    Description


    The purpose of this research study is to see whether using atezolizumab before surgery is safe and does not cause side effects that delay surgery in participants with cutaneous melanoma that has not spread to other areas of the body (non-metastatic) and can be removed by surgery (resectable) but has a higher risk of coming back after surgery (high-risk).